HomeVTGN • NASDAQ
add
Vistagen Therapeutics Inc
Previous close
$0.75
Day range
$0.71 - $0.75
Year range
$0.68 - $5.14
Market cap
28.09M USD
Avg Volume
4.06M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 258.00K | 40.98% |
Operating expense | 20.31M | 40.95% |
Net income | -19.42M | -49.81% |
Net profit margin | -7.53K | -6.26% |
Earnings per share | -0.54 | -28.57% |
EBITDA | -20.00M | -40.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.18M | -20.91% |
Total assets | 80.93M | -21.04% |
Total liabilities | 14.59M | 53.22% |
Total equity | 66.34M | — |
Shares outstanding | 39.50M | — |
Price to book | 0.44 | — |
Return on assets | -66.91% | — |
Return on capital | -78.75% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -19.42M | -49.81% |
Cash from operations | -13.76M | -26.39% |
Cash from investing | -94.00K | 98.79% |
Cash from financing | 27.65M | — |
Net change in cash | 13.80M | 173.91% |
Free cash flow | -6.73M | -7.63% |
About
Founded
1998
Headquarters
Website
Employees
59
